{
    "nctId": "NCT04390685",
    "briefTitle": "Prevention of Breast Cancer-related Lymphedma With Tacrolimus",
    "officialTitle": "Prevention of Breast Cancer-related Lymphedma With Tacrolimus",
    "overallStatus": "UNKNOWN",
    "conditions": "Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Breast cancer with planned ALND\n* postmenopausal or use of contraceptives\n* good general health condition\n* read and understand Danish\n\nExclusion Criteria:\n\n* Pregnant, breastfeeding it wishing to conceive with the next year\n* bilateral breast cancer\n* known allergy to tacrolimus or macrolides\n* known lymphedema\n* other malignant disease apart from keratinocyte cancer\n* in medical treatment for diabetes mellitus\n* known psychiatric condition which may influence participation\n* known renal or hepatic function",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}